The effects of varying acidity onHelicobacter pylorigrowth and the bactericidal efficacy of ampicillin

A Randomized, Comparative Trial of a Potassium-Competitive Acid Blocker (AZD0865) and Esomeprazole for the Treatment of Patients With Nonerosive Reflux Disease

(2013) John Dent et al.   AMERICAN JOURNAL OF GASTROENTEROLOGY

Rabeprazole 10 mg q.d.s. decreases 24-h intragastric acidity significantly more than rabeprazole 20 mg b.d. or 40 mg o.m., overcoming CYP2C19 genotype

(2012) M. Sugimoto et al.   ALIMENTARY PHARMACOLOGY & THERAPEUTICS

Management ofHelicobacter pyloriinfection—the Maastricht IV/ Florence Consensus Report

(2012) Peter Malfertheiner et al.   GUT

The elegance of the gastric mucosal barrier: designed by nature for nature

(2011) Kenneth E L McColl   GUT

Increasing the duration of dual amoxicillin plus omeprazole Helicobacter pylori eradication to 6 weeks: A pilot study

(2011) Taraq A Attumi et al.   JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY

A Study Comparing the Antisecretory Effect of TAK-438, a Novel Potassium-Competitive Acid Blocker, with Lansoprazole in Animals

(2011) Y. Hori et al.   JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS

Role of Omeprazole Dosage and Cytochrome P450 2C19 Genotype in Patients Receiving Omeprazole-Amoxicillin Dual Therapy forHelicobacter pyloriEradication

(2011) Jyh-Chin Yang et al.   PHARMACOTHERAPY

The pharmacodynamics and pharmacokinetics of S-tenatoprazole-Na 30 mg, 60 mg and 90 mg vs. esomeprazole 40 mg in healthy male subjects

(2010) R. H. HUNT et al.   ALIMENTARY PHARMACOLOGY & THERAPEUTICS

Helicobacter pylori and Esophageal Disease: Wake-up Call?

(2010) Martin J. Blaser   GASTROENTEROLOGY

Dual proton pump inhibitor plus amoxicillin as an empiric anti-H. pylori therapy: studies from the United States

(2010) David Y. Graham et al.   JOURNAL OF GASTROENTEROLOGY

Pylera®for the eradication ofHelicobacter pyloriinfection

(2009) Aamir Saleem et al.   Expert Review of Anti-Infective Therapy

Predictable prolonged suppression of gastric acidity with a novel proton pump inhibitor, AGN 201904-Z

(2008) R. H. HUNT et al.   ALIMENTARY PHARMACOLOGY & THERAPEUTICS